Due to the ongoing development of the COVID-19 pandemic, all Gailey Eye Clinic locations, including Bloomington Eye Institute and Gailey Eye Surgery-Decatur will remain closed until April 30th. Patients who have an appointment scheduled during our closure dates will be called to re-schedule for a future appointment date. For eye-related emergencies, please call your local Gailey Eye Clinic and you will be instructed on how to proceed. If you have any other questions or concerns, the best way to contact us during this time is via email at email@example.com. We will be monitoring email inquiries daily.
Gailey Eye Clinic is proud to have a Clinical Research Department. Our doctors and full-time research team are committed to conducting clinical trials to encourage cutting edge treatments in the field of ophthalmology. To ensure the rights and safety of our research patients, we are overseen by the Food and Drug Administration and national institutional review boards. We are also part of the Diabetic Retinopathy Clinical Research Network (DRCR).
We are currently conducting trials in the following areas:
Clinical trials are research studies that allow patients to participate in experimental, research treatments that are not offered to the general public. Clinical trials are generally sponsored by pharmaceutical companies, governmental agencies, or non-profit institutions. These therapies are generally not currently approved by the Food and Drug Administration (FDA) but data from these studies is often used to help obtain FDA approval.
Participation in clinical trials is never mandatory. We participate in clinical trials in order to be able to offer our patients with the latest therapies available for eye diseases.
Patients who are interested in participating in clinical trials should contact our Research Coordinator to inquire about current trials and eligibility. Please note that not everyone will be eligible to participate in the trial, as the criteria for inclusion (set by the FDA) are often very strict.